Vertex Pharmaceuticals Inc (VRTX) Com Stk
Sell:$484.27Buy:$484.65
$3.91
(0.81%)
NASDAQ:
2.20%
2.20%Market closed | Prices delayed by at least 15 minutes
- This stock can be held in a
Stocks and Shares ISASell:$484.27
Buy:$484.65
Change:$3.91
(0.81%)
$3.91
(0.81%)Market closed | Prices delayed by at least 15 minutes
Sell:$484.27
Buy:$484.65
Change:$3.91
(0.81%)
$3.91
(0.81%)Market closed | Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 18 February 2025 | Ourania (Nia) TatsisExecutive Vice President | Sell Option/Award related | 244 | $455.06 | $111,034.64 | 67,695 |
| 18 February 2025 | Jonathan Prim BillerChief Legal/Compliance Officer | Sell Option/Award related | 1,657 | $455.06 | $754,034.42 | 17,606 |
| 18 February 2025 | Kristen AmbroseChief Accounting Officer | Sell Option/Award related | 671 | $455.06 | $305,345.26 | 10,798 |
| 14 February 2025 | Reshma KewalramaniPresident/CEO | Sell Tax related | 6,553 | $463.46 | $3,037,053.38 | 129,380 |
| 14 February 2025 | Stuart A ArbuckleCOO | Sell Tax related | 2,724 | $463.46 | $1,262,465.04 | 74,722 |
| 14 February 2025 | Amit K. SachdevExecutive Vice President | Sell Tax related | 2,139 | $463.46 | $991,340.94 | 74,663 |
| 14 February 2025 | Ourania (Nia) TatsisExecutive Vice President | Sell Tax related | 2,293 | $463.46 | $1,062,713.78 | 67,939 |
| 14 February 2025 | Charles F Jr WagnerCFO | Sell Tax related | 2,293 | $463.46 | $1,062,713.78 | 63,241 |
| 14 February 2025 | David AltshulerChief Level Officer | Sell Tax related | 2,293 | $463.46 | $1,062,713.78 | 46,130 |
| 14 February 2025 | Carmen BozicOther Level A | Sell Tax related | 1,912 | $463.46 | $886,135.52 | 40,941 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 8 November 2024 | Reshma KewalramaniPresident/CEO | Sell Regular sell transaction (market) | 15,198 | $515.00 | $7,826,970.00 | 75,772 |
| 30 July 2024 | Reshma KewalramaniPresident/CEO | Sell Regular sell transaction (market) | 15,202 | $505.00 | $7,677,010.00 | 90,970 |
| 22 July 2024 | Reshma KewalramaniPresident/CEO | Sell Regular sell transaction (market) | 15,202 | $497.00 | $7,555,394.00 | 106,172 |
| 20 May 2024 | Reshma KewalramaniPresident/CEO | Sell Regular sell transaction (market) | 15,202 | $447.00 | $6,795,294.00 | 121,374 |
| 23 February 2024 | Reshma KewalramaniPresident/CEO | Sell Tax related | 9,386 | $431.79 | $4,052,780.94 | 136,507 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.